Concepedia

Katharina Zimmermann

KZ

15

Publications

1K

Citations

14

H-Index

2008

Active since

Affiliations

Medizinische Hochschule Hannover(Current)

Boston Children's Hospital

Harvard University

University of Cologne

University Hospital Münster

Katharina Zimmermann is an author at Medizinische Hochschule Hannover specializing in medicine, cell biology, and tumor immunity.

ORCID

Top concepts

Publications per year

2008–2024

15

Publications

15

Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor

Fatih Noyan, Katharina Zimmermann, Matthias Hardtke‐Wolenski et al. · American Journal of Transplantation · 2016 · 277 citations · Full text

Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes

Michel Tenspolde, Katharina Zimmermann, Leonie C. Weber et al. · Journal of Autoimmunity · 2019 · 201 citations · Full text

Design and Characterization of an “All-in-One” Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines

Katharina Zimmermann, Johannes Kuehle, Anna Christina Dragon et al. · Cancers · 2020 · 110 citations · Full text

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18

Wolfgang Glienke, Anna Christina Dragon, Katharina Zimmermann et al. · Frontiers in Immunology · 2022 · 62 citations · Full text

VPA response in SMA is suppressed by the fatty acid translocase CD36

Lutz Garbes, Ludwig Heesen, Irmgard Hölker et al. · Human Molecular Genetics · 2012 · 55 citations · Full text

, , +16

Rows per page

1–5 of 15